Literature DB >> 23652556

Can salivary phosphate levels be an early biomarker to monitor the evolvement of obesity?

Mor-Li Hartman1, Francisco Groppo, Mutsuko Ohnishi, J Max Goodson, Hatice Hasturk, Mary Tavares, Tina Yaskell, Constantino Floros, Kazem Behbehani, Mohammed S Razzaque.   

Abstract

Phosphate is an essential nutrient required for important biological reactions that maintain the normal homoeostatic control of the cell. The adverse effects of phosphate metabolism in obesity have not been studied in detail, chiefly because such an association is thought to be uncommon. However, in some animal models of obesity, serum phosphate levels were noted to be higher than the nonobese controls. For example, leptin-deficient (ob/ob) mice become severely obese and have high serum phosphate levels. In this study, we analyzed the phosphate content in saliva collected from children (n = 77; 10.5 ± 1.8) to evaluate association with body mass index; there is a significant increase of salivary phosphate content in obese compared to normal-weight children (ANOVA p < 0.001). The correlation coefficient (r) between BMI and phosphate was 0.33 (p = 0.0032). Our results suggest that the human salivary phosphate level may be an early biomarker of the genesis of obesity in children. The diagnostic importance lies in the fact that the salivary phosphate level could provide a noninvasive predictive marker in the development of obesity. Further studies will be required to understand the underlying mechanism of increased salivary phosphate accumulation in obese and overweight children. Nevertheless, its occurrence without systemic changes could be of diagnostic value, particularly in monitoring evolvement of obesity.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23652556      PMCID: PMC3896993          DOI: 10.1159/000346793

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


  37 in total

1.  Association of serum phosphate levels with glucose tolerance, insulin sensitivity and insulin secretion in non-diabetic subjects.

Authors:  M Haap; E Heller; C Thamer; O Tschritter; N Stefan; A Fritsche
Journal:  Eur J Clin Nutr       Date:  2006-01-04       Impact factor: 4.016

Review 2.  Can features of phosphate toxicity appear in normophosphatemia?

Authors:  Satoko Osuka; Mohammed S Razzaque
Journal:  J Bone Miner Metab       Date:  2012-01-05       Impact factor: 2.626

3.  Genetic induction of phosphate toxicity significantly reduces the survival of hypercholesterolemic obese mice.

Authors:  Mutsuko Ohnishi; Shigeko Kato; M Shawkat Razzaque
Journal:  Biochem Biophys Res Commun       Date:  2011-10-20       Impact factor: 3.575

Review 4.  Regulation of phosphate transport by fibroblast growth factor 23 (FGF23): implications for disorders of phosphate metabolism.

Authors:  Jyothsna Gattineni; Michel Baum
Journal:  Pediatr Nephrol       Date:  2009-08-11       Impact factor: 3.714

Review 5.  Clinical consequences of mutations in sodium phosphate cotransporters.

Authors:  Eleanor Lederer; Ken-ichi Miyamoto
Journal:  Clin J Am Soc Nephrol       Date:  2012-04-19       Impact factor: 8.237

Review 6.  The FGF23-Klotho axis: endocrine regulation of phosphate homeostasis.

Authors:  M Shawkat Razzaque
Journal:  Nat Rev Endocrinol       Date:  2009-11       Impact factor: 43.330

Review 7.  Adolescent bariatric surgery.

Authors:  Daniel S Hsia; Sara C Fallon; Mary L Brandt
Journal:  Arch Pediatr Adolesc Med       Date:  2012-08

8.  Is obesity an oral bacterial disease?

Authors:  J M Goodson; D Groppo; S Halem; E Carpino
Journal:  J Dent Res       Date:  2009-06       Impact factor: 6.116

9.  In vivo genetic evidence for suppressing vascular and soft-tissue calcification through the reduction of serum phosphate levels, even in the presence of high serum calcium and 1,25-dihydroxyvitamin d levels.

Authors:  Mutsuko Ohnishi; Teruyo Nakatani; Beate Lanske; M Shawkat Razzaque
Journal:  Circ Cardiovasc Genet       Date:  2009-09-21

10.  Expression of podoplanin and classical cadherins in salivary gland epithelial cells of klotho-deficient mice.

Authors:  Ikuko Amano; Yuri Imaizumi; Chiaki Kaji; Hiroshi Kojima; Yoshihiko Sawa
Journal:  Acta Histochem Cytochem       Date:  2011-11-05       Impact factor: 1.938

View more
  4 in total

1.  FGF23-induced hypophosphatemia persists in Hyp mice deficient in the WNT coreceptor Lrp6.

Authors:  Kazuyoshi Uchihashi; Teruyo Nakatani; Regina Goetz; Moosa Mohammadi; Xi He; Mohammed S Razzaque
Journal:  Contrib Nephrol       Date:  2013-05-03       Impact factor: 1.580

2.  5-Diphosphoinositol pentakisphosphate (5-IP7) regulates phosphate release from acidocalcisomes and yeast vacuoles.

Authors:  Evgeniy Potapenko; Ciro D Cordeiro; Guozhong Huang; Melissa Storey; Christopher Wittwer; Amit K Dutta; Henning J Jessen; Vincent J Starai; Roberto Docampo
Journal:  J Biol Chem       Date:  2018-10-12       Impact factor: 5.157

3.  Salivary phosphate as a biomarker for human diseases.

Authors:  Mohammed S Razzaque
Journal:  FASEB Bioadv       Date:  2022-01-03

4.  Phosphate Burden and Organ Dysfunction.

Authors:  Nikolay Mironov; Azeddine Atfi; Mohammed S Razzaque
Journal:  Front Aging       Date:  2022-07-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.